|
3-[4-(庚基氧基)-1,2,5-硫雜二氮雜環(huán)戊熳-3-基]吡啶
|
141064-09-7
|
Pemetrexed Impurity 87
|
培美曲塞雜質(zhì)87
|
|
Escitalopram oxalate impurity 08
|
草酸艾司西酞普蘭雜質(zhì)08
|
|
Azilsartan SM01-3
|
阿齊沙坦SM01-3
|
|
Azilsartan impurity C5-1
|
阿齊沙坦雜質(zhì)C5-1
|
|
Ruxolitinib Impurity SM2-F
|
蘆可替尼雜質(zhì)SM2-F
|
1865785-69-8
|
4-hydrazyl-1-methylazazeme hydrochloride
|
4-肼基-1-甲基氮雜?鹽酸鹽
|
|
Tofacitinib TF-S
|
托法替布TF-S
|
|
Fenomeline Impurity 13
|
呫諾美林雜質(zhì)13
|
|
|
多西他賽雜質(zhì)11
|
1584118-06-8
|
|
卡巴他賽雜質(zhì)
|
1714967-27-7
|
Z2-3,2'-(((5-(4-bromophenyl) pyrimidine-4,6-diyl)bis (oxy)bis(ethane-2,1-diyl))bis(oxy)bis(5-bromopyrimidine)
|
Z2-3,2'-(((5-(4-溴苯基)嘧啶-4,6-二基)雙(氧)雙(乙烷-2,1-二基))雙(氧)雙(氧)雙(5-溴嘧啶)
|
|
YD-202-Z3
|
YD-202-Z3
|
|
Amlodipine Impurity 1
|
氨氯地平雜質(zhì)1
|
113994-41-5
|
Esmolol Hydrochloride impurity A
|
鹽酸艾司洛爾雜質(zhì)A
|
|
N-[4-(7-chloro-2,3,4,5-tetrahydro-5-oxo-1-benzoazazine-1-formyl)-3-methylphenyl]-2-methylbenzamide
|
N-[4-(7-氯-2,3,4,5-四氫-5-氧代-1-苯并氮雜卓-1-甲?;?-3-甲基苯基]-2-甲基苯甲酰胺
|
|
Cyclic control
|
環(huán)合物對照品
|
|
Dabiga-etexilate mesylate impurity R (IMP R) control
|
甲磺酸達比加群酯雜質(zhì)R(IMP R)對照品
|
|
|
甲磺酸達比加群酯中間體II雜質(zhì)11(DBZII IMP11)對照品
|
|
|
甲磺酸達比加群酯中間體II雜質(zhì)10(DBZII IMP10)對照品
|
|
|
甲磺酸達比加群酯雜質(zhì)Q
|
|
Aproxitentan impurity II-1
|
阿普昔騰坦雜質(zhì)II-1
|
1642873-04-8
|
Esmolol hydrochloride impurity I.
|
鹽酸艾司洛爾雜質(zhì)Ⅰ
|
81148-15-4
|
Aproxitentan impurity C
|
阿普昔騰坦雜質(zhì)C
|
1803092-45-6
|
Escitalopram oxalate impurity 06
|
草酸艾司西酞普蘭雜質(zhì)06
|
1187671-15-3
|
Methotrexate ImpuritySM3-4
|
甲氨蝶呤雜質(zhì)SM3-4(L-谷氨酸,N-[4-(甲氨基)苯甲酰基]-,1-甲酯)
|
79974-20-2
|
Tofacitinib TF-6
|
托法替布TF-6
|
477600-73-0
|
Aprexittan impurity SM1-3
|
阿普昔騰坦雜質(zhì)SM1-3
|
17802-65-2
|
Escitalopram oxalate impurity 02
|
草酸艾司西酞普蘭雜質(zhì)02
|
865435-44-5
|
Aproxitentan impurity E
|
阿普昔騰坦雜質(zhì)E
|
2253990-09-7
|
(Albuterol impurity) aminoketone hydrochloride
|
(沙丁胺醇雜質(zhì))鹽酸胺基酮
|
115787-52-5
|
3-Fluorobenzal Bromide
|
3-氟苯亞甲基二溴
|
455-34-5
|
Anastrozole monoamide control
|
阿那曲唑單酸單酰胺對照品
|
2469244-33-3
|
N-Nitrosodiethanolamine
|
N-亞硝基二乙醇胺
|
1116-54-7
|
N1-(2-cyanobenzyl)-3-aminopiperidine
|
N1-(2-氰基芐基)-3-氨基哌啶
|
1353254-17-7
|
2-Amino-5-(2-fluorophenyl)-furan-3-nitrile
|
2-氨基-5-(2-氟苯基)-呋喃-3-腈
|
312307-69-0
|
Isotachysterol
|
異速甾醇
|
469-06-7
|
Dehydro Benidipine
|
脫氫貝尼地平
|
118935-44-7
|
1-(3-methoxyphenyl)-4-nitrosopiperazine
|
1-(3-甲氧基苯基)-4-亞硝基哌嗪
|
2763779-41-3
|
Categravir Impurity 06
|
卡替拉韋雜質(zhì)06
|
1335210-31-5
|
Levofloxacin Impurity B
|
左氧氟沙星雜質(zhì)B
|
117707-40-1
|
CalciuM Saccharate
|
葡萄糖二酸鈣
|
5793-89-5
|
Dapagliflozin impurities 2
|
達格列凈雜質(zhì)2
|
960404-62-0
|
Glycopyrrolate Impurity I
|
格隆溴銨雜質(zhì)I
|
1404453-68-4
|
Ethperisone hydrochloride impurity E
|
鹽酸乙哌立松雜質(zhì)E
|
70639-76-8
|
Ethperisone hydrochloride impurity D
|
鹽酸乙哌立松雜質(zhì)D
|
2608845-70-9
|
5,6-monoepoxy Vitamin A
|
5,6-單環(huán)氧維生素A
|
512-39-0
|
FSM/Impurity G
|
FSM/雜質(zhì)G
|
2309462-39-1
|
Caffeidine
|
咖啡亭
|
20041-90-1
|
Indacaterol acetate
|
醋酸茚達特羅
|
1000160-96-2
|
Adrenochrome
|
腎上腺素紅
|
0054-06-8
|
N,N-Bis((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)pyridine-3-sulfonamide
|
N,N-雙{[5-(2-氟苯基)-1H-吡咯-3-基]甲基}吡啶-3-磺酰胺
|
2514957-29-8
|
2-Ethoxy-N-Hydroxy Benzamidine
|
雜質(zhì)SM01-3 (2-乙氧基-N-羥基苯甲脒)
|
879-57-2
|
Ethperisone hydrochloride impurity F
|
鹽酸乙哌立松雜質(zhì)F
|
119651-20-6
|
YMXT/Impurity C
|
YMXT/雜質(zhì)C
|
2059988-39-3
|
Dronedarone hydrochloride impurity SM1-7
|
鹽酸決奈達隆雜質(zhì)SM1-7
|
|
Dronedarone hydrochloride impurity SM1-6
|
鹽酸決奈達隆雜質(zhì)SM1-6
|
|
Dronedarone hydrochloride impurity SM1-11
|
鹽酸決奈達隆雜質(zhì)SM1-11
|
|
Letemovir Impurity C
|
來特莫韋雜質(zhì)C
|
|
Z5-3 (Methyl Impurity)
|
Z5-3(甲基雜質(zhì))
|
|
XT-D Impurity 2
|
XT-D雜質(zhì)2
|
|
XT-C Impurity 1
|
XT-C雜質(zhì)1
|
|
Z5-4 (dimethyl impurity)
|
Z5-4(雙甲基雜質(zhì))
|
|
A-95-(4-bromophenyl)-6-chloroprrimidin-4-o1
|
A-95-(4-溴苯基)-6-氯咯啶-4-o1
|
|
Sitafloxacin ZZ-05
|
西他沙星ZZ-05
|
|
|
阿維巴坦雜質(zhì)13
|
2760721-25-1
|
Sitafloxacin ZZ-04
|
西他沙星ZZ-04
|
|
Sitafloxacin ZZ-02
|
西他沙星ZZ-02
|
|
Vitamin A palmitate dimer
|
維生素A棕櫚酸酯二聚體
|
|
Sitafloxacin ZZ-06
|
西他沙星ZZ-06
|
|
Sitafloxacin ZZ-07
|
西他沙星ZZ-07
|
|
|
(S)-5-氨基-2-羥基-5-氧代戊酸
|
53363-45-4
|
CarfilzoMib IMpurity 91
|
卡非佐米雜質(zhì)91
|
|
|
2-(4-甲氧基芐基)苯酚
|
21388-77-2
|
|
4-(4-甲氧基芐基)苯酚
|
37155-50-3
|
Amorolfine EP Impurity B
|
阿莫羅芬EP雜質(zhì)B
|
142347-84-0
|
Dronedarone hydrochloride impurity SM1-12
|
鹽酸決奈達隆雜質(zhì)SM1-12
|
856758-05-9
|
Dronedarone hydrochloride impurity SM1-13
|
鹽酸決奈達隆雜質(zhì)SM1-13
|
141645-17-2
|
XT-D Impurity 3
|
XT-D雜質(zhì)3
|
144216-11-5
|
Methotrexate Impurity D
|
甲氨蝶呤雜質(zhì)D
|
5623-18-7
|
N-Methyl-2-(phenylmethoxy)-ethanamine
|
2-(芐基氧基)-N-甲基乙烷-1-胺
|
71126-62-0
|
Oxyxicillin sulfoxide
|
氧西林亞砜
|
36231-30-8
|
Sitafloxacin SSR
|
西他沙星-SSR
|
127254-11-9
|
4- (1-hydroxy-1-methylethyl) -2-propyl -1H-imidazole-5- acetyl
|
4-(1-羥基-1-甲基乙基)-2-丙基-1H-咪唑-5-乙酰(咪唑單酯雜質(zhì)A)對照品
|
2411637-68-6
|
Liaosi Gua-M3- Impurity F reference standard
|
利奧西呱-M3-雜質(zhì)F對照品
|
|
Standard substance of Oseltamivir phosphate intermediate S001M6P38
|
磷酸奧司他韋中間體S001M6P38標準品
|
|
Ruxolitinib INT1-B
|
蘆可替尼 INT1-B
|
|
7-ACCA-RC
|
7-ACCA-RC
|
|
7-AMCA Polymer
|
7-AMCA聚合物
|
|
Methotrexate Impurity A
|
甲氨蝶呤雜質(zhì)A
|
945-24-4
|
Azilsartan Impurity C2 (2-N-(t-Butoxycarboxyl)amino-3-nitrobenzoate ethyl ester)
|
阿齊沙坦雜質(zhì)C2(2-N-(t-丁氧甲?;?氨基-3-硝基苯甲酸乙酯)
|
136285-65-9
|
N-(Triphenylmethyl)-5-(4',4'-dibromo-biphenyl-2-yl)tetrazole reference standard
|
358685-13-9
|
Dronedarone hydrochloride impurity SM1-15
|
鹽酸決奈達隆雜質(zhì)SM1-15
|
141645-20-7
|
4-acetyl-2-propyl -1H-imidazole-5-carboxylic acid ethyl ester
|
4-乙酰-2-丙基-lH-咪唑-5-羧酸乙酯(咪唑單酯雜質(zhì)B)對照品
|
144690-07-3
|
Methotrexate Impurity J
|
甲氨蝶呤雜質(zhì)J
|
34378-65-9
|
AMLF101-Z4
|
|
2828725-49-9
|
(2R,4S)5-([1,1'-biphenyl]-4-yl)-4-succinic acid monoamido-3-methyl-valeric acid ethyl ester
|
(2R,4S)5-([1,1'-聯(lián)苯]-4-基)-4-丁二酸單酰胺基-3-甲基-戊酸乙酯
|
761373-05-1
|
Pentanedioic acid, 2,4-diacetyl-3-(3-nitrophenyl)-, dimethyl ester
|
2,4-二乙?;?3-(3-硝基苯基)戊二酸二甲酯
|
89080-61-5
|
Ruxolitinib INT1-E
|
蘆可替尼 INT1-E
|
|
Empagliflozin P5-6
|
艾托格列凈P5-6
|
|